Research Article
Incidence and Prognostic Factors for Legionnaires' Disease in Denmark 1993–2006
Table 2
Number and proportion of patients in each comorbidity group for different exposure categories; notified, confirmed cases of LD, Denmark 1993–2006, .
| Comorbidity group | All patients number (%) | Travel associated number (%) | Hospital acquired number (%) | Community acquired, nontravel number (%) |
| Alcohol related diagnoses | 45 (4.0%) | 8 (2.7%) | 7 (4.2%) | 30 (4.6%) | Cardiovascular diseases | 332 (30%) | 65 (22%) | 84 (51%) | 183 (28%) | Pulmonary diseases | 376 (34%) | 74 (25%) | 67 (40%) | 235 (36%) | Immune deficiency diseases | 50 (4.5%) | 9 (3.0%) | 21 (13%) | 20 (3.1%) | Infectious diseases1 | 153 (14%) | 29 (10%) | 38 (23%) | 96 (13%) | Neurological diseases | 42 (3.8%) | 7 (2.3%) | 10 (6.0%) | 25 (3.9%) | Renal diseases | 205 (18%) | 42 (14%) | 46 (28%) | 117 (18%) | Gastroenterological diseases | 193 (17%) | 39 (13%) | 53 (32%) | 101 (16%) | Diabetes | 104 (9.3%) | 32 (11%) | 13 (7.8%) | 59 (9.1%) | Malignancy | 150 (13%) | 18 (6.0%) | 57 (34%) | 75 (12%) | Others2 | 230 (21%) | 31 (10%) | 67 (40%) | 132 (20%) |
|
|
1Excluding Legionnaires’ disease.
2Rheumatologic diseases, endocrine diseases (except diabetes), nonmalignant haematological diseases.
|